DIFFERENTIAL GROWTH-REGULATION OF A METASTATIC HUMAN LUNG-CARCINOMA CELL-LINE THROUGH ACTIVATION OF PHOSPHATIDYL-INOSITOL TURNOVER SIGNAL-TRANSDUCTION PATHWAY
Wg. Fang et Bq. Wu, DIFFERENTIAL GROWTH-REGULATION OF A METASTATIC HUMAN LUNG-CARCINOMA CELL-LINE THROUGH ACTIVATION OF PHOSPHATIDYL-INOSITOL TURNOVER SIGNAL-TRANSDUCTION PATHWAY, Clinical & experimental metastasis, 11(4), 1993, pp. 330-336
Until recently, the signal transduction pathways involved in the proce
sses of tumor growth have been poorly understood. In the present study
, we investigated cell surface receptors which utilize phosphatidylino
sitol (P1) turnover/Ca2+ mobilization as a signal transduction pathway
to regulate cell growth in a metastatic human lung carcinoma cell lin
e, PG. We found that purinoceptor agonists, including ATP and its anal
ogs, and bombesin, an amphibian tetradeca-peptide of mammalian homolog
y gastrin-releasing peptide, induced rapid transient increase of cytop
lasmic-free Ca2+ in PG cells loaded with fura-2. The Ca2+ responses we
re derived both from release from internal stores and the opening of p
lasma membrane Ca2+ channels. HPLC analysis of inositol 1,4,5-triphosp
hate (Ins(1,4,5)P3) and its isomers showed a receptor-linked phospholi
pase C activation by ATP and bombesin. Although ATP and bombesin were
both able to induce P1 turnover and Ca2+ mobilization in PG cells, the
y had differential growth regulatory effects on PG cells. Treatment wi
th bombesin stimulated PG cell growth while treatment with ATP inhibit
ed significantly PG cell growth. Pharmacological studies showed that t
he purinoceptors on PG cells were of the P2 subtype. Other hydrolysis-
resistant P2 purinoceptor agonists, including ATPgammaS and AMP-PNP, w
ere as effective as ATP in stimulating P1 turnover and Ca2+ mobilizati
on as well as in inhibiting PG cell growth in vitro, suggesting the po
tential usefulness of such ATP analogs in clinical trials. Preliminary
results suggest G protein involvement in the differential regulation
of ATP and bombesin signal transduction pathways.